Today's hub blueprint: Lock in on the journey
A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies
All about the journey
Catchphrase or not, the patient journey is seemingly more complex than ever these days—upping the ante for new strategies in specialty-care support
Specialty access barriers: How technology can help
2020 was a difficult year for many patients, but new data may signal a brighter future ahead
Keeping the message moving during Covid
A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb
Rethinking NCPs in support mix
Non-commercial pharmacies can be secret weapons for intake and adherence
Hybrid hubs and today's patient-centric push
Their promise is prompting pharma leaders to give their hub/PAP CRM platforms a closer look
Health policies high on specialty radar in 2021
The key trends and considerations for specialty providers navigating a changing policy landscape
The legal landscape for patient support services
More leverage for community-based pharmacies and rules changes for drug-pricing reporting
Raising the stakes for market access support
Case study on closing the gap between new specialty drugs and specialty pharmacies
